Neil Udassi

Neil Udassi is an Analyst at Alpha Wave Global, LP, a Miami Beach-based investment firm, where he has been specializing in life science public and private investments since February 2023. In this role, he is responsible for conducting in-depth research, financial modeling, and due diligence on investment opportunities within the life sciences sector, supporting both public and private market strategies.

Neil’s investment focus is specifically on the life sciences industry, covering areas such as biotechnology, pharmaceuticals, and healthcare innovation. His expertise includes evaluating both public equities and private company investments, with a strong emphasis on identifying emerging trends and high-growth opportunities in the sector.

Prior to joining Alpha Wave Global, Neil held positions as a Fellow at F-Prime Capital and as a Blavatnik Associate with Yale Ventures. He also previously worked as an Analyst at Marshall Wace, focusing on life science long/short equity, and as a Business Development Analyst at Biohaven. Neil holds a Bachelor of Science degree in Molecular, Cellular & Developmental Biology and Economics from Yale University, graduating magna cum laude and as a member of Phi Beta Kappa. His background combines deep scientific knowledge with financial acumen, enabling him to bridge the gap between complex life science innovations and investment analysis.